NTM pulmonary disease – Patient Worthy

First Patient Enrolled in NUZYRA Trial for NTM Lung Disease

Post author:Jessica Lynn
Post published:November 16, 2021
Post category:Nontuberculous Mycobacteria (NTM) Lung Diseas Nontuberculous Mycobacteria Lung Disease

On October 18, 2021, biopharmaceutical company Paratek Pharmaceuticals, Inc. ("Paratek") shared via news release that the first patient had enrolled in a Phase 2b clinical trial. Within the trial, researchers…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

First Patient Enrolled in NUZYRA Trial for NTM Lung Disease

Why Your Voice in Research Matters: Groundbreaking Studies are Changing What's Possible

Rethinking What It Means to Live With Acromegaly

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

Let’s Work Together!

Keep Up to Date

Learn More